Medical Xpress
MAY 6, 2023
For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
BioSpace
MAY 6, 2023
Citing insufficient safety evidence for one of the drug’s main ingredients, the regulator in a Complete Response Letter rejected the company’s application for Parkinson’s disease candidate IPX203.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
MAY 6, 2023
More than three years after the coronavirus began ravaging the planet, the World Health Organization (WHO) announced Friday that the pandemic is no longer a public emergency.
Pharma Marketing Network
MAY 6, 2023
As artificial intelligence (AI) continues to advance, it is becoming increasingly common for pharmaceutical marketers to use AI to write their marketing and customer-facing communications. While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination.
Medical Xpress
MAY 6, 2023
Women who have suffered domestic abuse may have a higher risk of developing atopic diseases including asthma, new research has found.
Drug Patent Watch
MAY 6, 2023
Annual Drug Patent Expirations for NOCDURNA Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are ten… The post New patent expiration for Ferring Pharms drug NOCDURNA appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
MAY 6, 2023
This chart shows the pharmaceutical companies with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in Hong Kong? appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
MAY 6, 2023
The pharmaceutical giant is tapping the world’s largest biomanufacturing facility operated by Samsung Biologics for biosimilar production.
BioSpace
MAY 6, 2023
The company has signed a memorandum of understanding and land collaboration agreement to develop medicines exclusively for Chinese use.
BioSpace
MAY 6, 2023
Pharmas, advocacy groups and regulatory bodies have made moves to put each other in legal crosshairs in 2023. Follow along with BioSpace’s Lawsuit Tracker to see what’s piling up on the docket.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Expert insights. Personalized for you.
103 
Let's personalize your content